image
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 4.54
-14.3 %
$ 2.35 M
Market Cap
0.0
P/E
BALANCE SHEET
6.75 M ASSETS
-27.17%
1.1 M LIABILITIES
-47.08%
5.66 M EQUITY
-21.45%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition ENDRA Life Sciences Inc.
image
Current Assets 3.03 M
Cash & Short-Term Investments 2.83 M
Receivables 0
Other Current Assets 199 K
Non-Current Assets 3.72 M
Long-Term Investments 0
PP&E 466 K
Other Non-Current Assets 3.26 M
Current Liabilities 903 K
Accounts Payable 360 K
Short-Term Debt 202 K
Other Current Liabilities 340 K
Non-Current Liabilities 192 K
Long-Term Debt 192 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014
ASSETS
Cash & Cash Equivalents 2.8 4.9 9.5 7.2 6.2 6.5 5.6 0.1 19.1 K 0.2
Short Term Investments 0 0 0 0 0 0 0 0 0 0
Receivables 0 0 (1.3) 0 0 0 6.85 K 0 0 0
Inventory 0 2.6 1.3 0.6 0.1 59.4 K 0.2 40.1 K 99 K 0.2
Other Current Assets 0.2 1.0 2.7 0.4 0.2 0.4 81.7 K 10.5 K 8.49 K 8.99 K
Total Current Assets 3.0 8.5 12.1 8.2 6.5 6.9 5.9 0.2 0.1 0.4
PP&E 0.5 0.7 0.8 0.6 0.6 0.3 0.2 0.3 0.4 0.3
Intangible Assets 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 3.3 5.99 K 5.99 K 0 0 0 0 0 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0
Total Assets 6.8 9.3 12.9 8.8 7.2 7.2 6.1 0.5 0.5 0.7
LIABILITIES
Accounts Payable 0.4 0.6 0.8 0.4 1.3 0.6 0.8 0.2 80.9 K 11.5 K
Short Term Debt 0.2 0.2 0.3 0.2 0.4 0 0 0.9 0 0
Other Current Liabilities 0.3 0.9 0.5 0.4 0.4 0.3 68 K 0.2 0.2 86.1 K
Total Current Liabilities 0.9 1.7 1.5 1.0 2.1 1.0 0.8 1.4 0.2 97.6 K
Long Term Debt 0.2 0.4 0.5 0.6 0.3 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0 1 0
Total Liabilities 1.1 2.1 2.1 1.6 2.4 1.0 0.8 1.4 0.2 97.6 K
EQUITY
Common Stock 1.04 K 317 4.25 K 3.4 K 842 742 392 253 253 200
Retained Earnings (91.9) (81.9) (68.7) (57.3) (45.2) (27.7) (17.9) (12.5) (9.7) (7.5)
Other Accumulative Comprehensive Income/Loss 5.23 K 6.07 K 13.9 K 10.8 K 43.5 K (0.4) (0.3) (0.3) (0.2) (0.2)
Total Equity 5.7 7.2 10.8 7.2 4.8 6.2 5.3 (0.9) 0.3 0.6
Total Liabilities and Equity 6.8 9.3 12.9 8.8 7.2 7.2 6.1 0.5 0.5 0.7
SHARES OUTSTANDING
Common Shares Outstanding 9.0 2.9 2.0 1.0 0.4 0.2 0.1 0.2 0.2 0.2